» Articles » PMID: 23140643

Metabolomics Identifies an Inflammatory Cascade Involved in Dioxin- and Diet-induced Steatohepatitis

Overview
Journal Cell Metab
Publisher Cell Press
Date 2012 Nov 13
PMID 23140643
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is among the most potent environmentally toxic compounds. Serum metabolomics identified azelaic acid monoesters as significantly increased metabolites after TCDD treatment, due to downregulation of hepatic carboxylesterase 3 (CES3, also known as triglyceride hydrolase) expression in an arylhydrocarbon receptor (AhR)-dependent manner in mice. The decreased CES3 expression was accomplished by TCDD-stimulated TGFβ-SMAD3 and IL6-STAT3 signaling, but not by direct AhR signaling. Methionine- and choline-deficient (MCD) diet-treated mice also showed enhanced serum azelaic acid monoester levels after attenuation of hepatic CES3 expression, while db/db mice did not, thus suggesting an association with steatohepatitis. Forced expression of CES3 reversed serum azelaic acid monoester/azelaic acid ratios and hepatic TGFβ mRNA levels in TCDD- and MCD diet-treated mice and ameliorated steatohepatitis induced by MCD diet. These results support the view that azelaic acid monoesters are possible indicators of TCDD exposure and steatohepatitis and suggest a link between CES3, TGFβ, and steatohepatitis.

Citing Articles

Induction of MASH-like pathogenesis in the Nwd1 mouse liver.

Yamada S, Ogawa H, Funato M, Kato M, Nakadate K, Mizukoshi T Commun Biol. 2025; 8(1):348.

PMID: 40069352 PMC: 11897295. DOI: 10.1038/s42003-025-07717-5.


Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes.

Im S, Kang S, Son W, Son M, Oh S, Yoon H Int J Mol Sci. 2024; 25(22).

PMID: 39596044 PMC: 11594116. DOI: 10.3390/ijms252211974.


The metabolomics analysis of cecal contents elucidates significant metabolites involved in the therapeutic effects of total flavonoids derived from Sonchus arvensis L. in male C57BL/6 mice with ulcerative colitis.

Chang N, Wei W, Wang S, Hou S, Sui Y, Taoyang Heliyon. 2024; 10(12):e32790.

PMID: 39005925 PMC: 11239596. DOI: 10.1016/j.heliyon.2024.e32790.


Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology.

Jin Y, Ma Y, Zhang M, Xia W, Yuan P, Li B Amino Acids. 2024; 56(1):11.

PMID: 38319413 PMC: 10847190. DOI: 10.1007/s00726-023-03363-5.


Mitigation of Insulin Resistance by Natural Products from a New Class of Molecules, Membrane-Active Immunomodulators.

Izbicka E, Streeper R Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513825 PMC: 10386479. DOI: 10.3390/ph16070913.


References
1.
Kale R . Post-irradiation free radical generation: evidence from the conversion of xanthine dehydrogenase into xanthine oxidase. Indian J Exp Biol. 2004; 41(2):105-11. View

2.
Nebert D, Dalton T, Okey A, Gonzalez F . Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 2004; 279(23):23847-50. DOI: 10.1074/jbc.R400004200. View

3.
Idle J, Gonzalez F . Metabolomics. Cell Metab. 2007; 6(5):348-51. PMC: 2140247. DOI: 10.1016/j.cmet.2007.10.005. View

4.
Jaeschke H . Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J Gastroenterol Hepatol. 2011; 26 Suppl 1:173-9. DOI: 10.1111/j.1440-1746.2010.06592.x. View

5.
Rifkind A . CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab Rev. 2006; 38(1-2):291-335. DOI: 10.1080/03602530600570107. View